Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS
Phase 1
Not yet recruiting
- Conditions
- COVID-19Acute Respiratory Distress SyndromeARDS
- Interventions
- Biological: Human umbilical cord mesenchymal stem cells + best supportive careOther: Placebo control + best supportive care
- First Posted Date
- 2020-06-30
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Baylx Inc.
- Target Recruit Count
- 39
- Registration Number
- NCT04452097
Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis
Phase 1
Not yet recruiting
- Conditions
- Rheumatoid Arthritis
- Interventions
- Biological: PlaceboBiological: hUC-MSC suspension
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Baylx Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT03828344
© Copyright 2025. All Rights Reserved by MedPath